Follow
Raytelligence AB
NGM Nordic SME (Sweden)
Raytelligence is a medical technology company. Currently the company specialises on the analysis and reading of heart rates and various movement patterns. The technology is based on the company's proprietary platform and uses radar technology, where the company focuses on delivering products and associated services to the healthcare sector and well as the industrial sector. The head office is located in Halmstad.
Sector:
TECHNOLOGY
>
Hardware
Rights issue
Price
3.60 SEK
Subscription period
29 Oct - 12 Nov 2020
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Type
Ticker
ISIN
Market
SHARE
RAYTL
SE0011721356
NGM Nordic SME
Sweden (SE)
Details of share in Raytelligence AB with ticker RAYTL
Status
Active
Order book id
4TLK
Amount of instruments
14 604 913
Par value
0.0705
Market cap
61 340 634.00 SEK
Currency
SEK
Segment
Nordic SME Sweden
First trading date
20 Dec 2018
Terms
Type
Price
Pre-money valuation
Time
Files
IPO
7.05 SEK
49.97M SEK
01 Nov - 22 Nov 2018
IPO in Raytelligence AB
Type
Price
Pre-money valuation
Time
Files
Rights issue
2.60 SEK
21.7M SEK
28 Oct - 11 Nov 2019
Share issue in Raytelligence AB
Type
Price
Pre-money valuation
Time
Files
Rights issue
2.60 SEK
32.55M SEK
24 Apr - 08 May 2020
Share issue in Raytelligence AB
Type
Price
Pre-money valuation
Time
Files
Rights issue
3.60 SEK
52.58M SEK
29 Oct - 12 Nov 2020
Share issue in Raytelligence AB
People
Klas Arvidson
CEO
Jonas Vikbladh
Chairman of the board
Arvidson Klas Jerker
Board member
Viberg Per-Arne Gunnar
Board member
Martinsson Leif Peter Henry
Board member
Company Details
Sector
TECHNOLOGY

Address
Klammerdammsgatan 6
Zip code
302 42
City/district
Halmstad
Country
Sweden (SE)
Registration number
559039-7088
LEI code
549300VV0K7EC1ZOCI71
First trade date
20 Dec 2018
Registration date
08 Dec 2015
Short name
Raytelligence

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More

Create Your FREE Account to stay Up To Date